Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial

被引：0
|
作者：
Ju Yup Lee
Nayoung Kim
Kyung Sik Park
Hyun Jin Kim
Seon Mee Park
Gwang Ho Baik
Ki-Nam Shim
Jung Hwan Oh
Suck Chei Choi
Sung Eun Kim
Won Hee Kim
Seon-Young Park
Gwang Ha Kim
Bong Eun Lee
Yunju Jo
Su Jin Hong
机构：
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Keimyung University School of Medicine,Department of Internal Medicine
[3] Gyeongsang National University School of Medicine,Department of Internal Medicine and Institute of Health Science
[4] College of Medicine,Department of Internal Medicine
[5] Chungbuk National University,Department of Internal Medicine
[6] Hallym University College of Medicine,Department of Internal Medicine
[7] Chuncheon Sacred Heart Hospital,Departments of Internal Medicine, College of Medicine
[8] Ewha Womans University School of Medicine,Department of Internal Medicine
[9] The Catholic University of Korea,Department of Internal Medicine
[10] Wonkwang University School of Medicine,Digestive Disease Center, CHA Bundang Medical Center
[11] Kosin University College of Medicine,Department of Internal Medicine
[12] CHA University,Department of Internal Medicine
[13] Chonnam National University Medical School,Department of Internal Medicine
[14] Pusan National University School of Medicine and Biomedical Research Institute,Department of Internal Medicine and Research Institute
[15] Pusan National University Hospital,undefined
[16] Eulji General Hospital,undefined
[17] Eulji University School of Medicine,undefined
[18] Soonchunhyang University College of Medicine,undefined
来源：
BMC Gastroenterology | / 16卷
关键词：
Eradication; Amoxicillin; Tetracycline; Bismuth; Quadruple;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
    Fu, Wei
    Song, Zhiqiang
    Zhou, Liya
    Xue, Yan
    Ding, Yu
    Suo, Baojun
    Tian, Xueli
    Wang, Li
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (06) : 1580 - 1589
  • [12] Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
    Wei Fu
    Zhiqiang Song
    Liya Zhou
    Yan Xue
    Yu Ding
    Baojun Suo
    Xueli Tian
    Li Wang
    Digestive Diseases and Sciences, 2017, 62 : 1580 - 1589
  • [13] Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
    Cheung, Ka Shing
    Lyu, Tao
    Deng, Zijie
    Han, Shaowei
    Ni, Li
    Wu, Juan
    Tan, Jing Tong
    Qin, Jian
    Ng, Ho Yu
    Leung, Wai K.
    Seto, Wai-Kay
    HELICOBACTER, 2024, 29 (05)
  • [14] Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial
    Cho, Jun-Hyung
    Jin, So Young
    Park, Suyeon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 923 - 929
  • [15] EFFICACY AND TOLERABILITY OF FOURTEEN-DAY SEQUENTIAL QUADRUPLE REGIMEN: PANTOPRAZOLE, BISMUTH, AMOXICILLIN, METRONIDAZOLE AND OR FURAZOLIDONE AS FIRST-LINE THERAPY FOR ERADICATION OF HELICOBACTER PYLORI: A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL
    Mansour-Ghanaei, Fariborz
    Samadi, Alireza
    Joukar, Farahnaz
    Fakheri, Hafez Tirgar
    Hassanipour, Soheil
    Ashoobi, Mohammad Taghi
    Soltanipour, Soheil
    Alizadeh, Ahmad
    Rezamand, Gholamreza
    Fathalipour, Mohammad
    EXCLI JOURNAL, 2019, 18 : 644 - 652
  • [16] Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
    Yang, Jing
    Zhang, Yi
    Fan, Ling
    Zhu, Yang-Jie
    Wang, Ting-Yi
    Wang, Xing-Wei
    Chen, Dong-Feng
    Lan, Chun-Hui
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03) : 437 - 445
  • [17] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, Ahmet
    Kadayifci, Abdurrahman
    Safali, Mukerrem
    Ilgan, Seyfettin
    Bagci, Sait
    JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (04) : 211 - 215
  • [18] The effects of sequential treatment as a first-line therapy for Helicobacter pylori eradication
    Demir, Mehmet
    Ataseven, Hilmi
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2011, 41 (03) : 427 - 433
  • [19] Sequential therapy versus quadruple therapy for Helicobacter pylori eradication: A prospective double-blinded randomized controlled trial
    Tabesh, Elham
    Yadmehr, Farzad
    Feizi, Awat
    Khorvash, Farzin
    Sindarreh, Setayesh
    Hakamifard, Atousa
    HEALTH SCIENCE REPORTS, 2024, 7 (01)
  • [20] First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy
    Tarhini, Mandi
    Fayyad-Kazan, Mohammad
    Fayyad-Kazan, Hussein
    Mokbel, Mahmoud
    Nasreddine, Mohammad
    Badran, Bassam
    Kchour, Ghada
    MICROBIAL PATHOGENESIS, 2018, 117 : 23 - 26
12345